CAS: 1628614-50-5
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one REF: 3D-DQC61450CAS: 1628614-50-5 | Min. 95% | A consultar | Qui 11 Jul 24 |
 | XMD-17-51 REF: TM-T22460CAS: 1628614-50-5 | 98% | 907,00 €~2.337,00 € | Qui 18 Jul 24 |
![5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one](https://static.cymitquimica.com/products/3D/thumb/DQC61450.jpg)
5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
CAS:1628614-50-5
5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one is a small molecule that binds to the Nmethyl D aspartate receptor (NMDAR). It …
Fórmula:
C21H24N8O
Pureza:
Min. 95%
Peso molecular:
404.5 g/mol
Ref: 3D-DQC61450
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 11 de Julho de 2024
XMD-17-51
CAS:1628614-50-5
XMD-17-51 is a potent and highly selective NUAK1 inhibitor.
Fórmula:
C21H24N8O
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
404.47
Ref: TM-T22460
| 25mg | 1.410,00 € | |
| 50mg | 1.851,00 € | |
| 100mg | 2.337,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 18 de Julho de 2024
